Upload Button Icon Add office photos
filter salariesFilter salaries by

Apollo Cancer Institute Clinical Research Associate salaries in India

Annual salary range
0 - 2 years exp.
₹2.9 Lakhs - ₹3.7 Lakhs
Low Confidence
info icon
Low confidence means that this average salary is based on data that was reported by very few people.
Salary of majority employees
unlock blur
unlock blur

Interested in this particular role?

Last Updated: 13 Sep 2024

Companies similar to Apollo Cancer Institute for Clinical Research Associate

Company name Avg Annual Salary Open Jobs
unlock blur

₹3.5 L/yr - ₹4.5 L/yr

arrow icon 16% more
unlock blur

₹2.4 L/yr - ₹3.5 L/yr

arrow icon 10% less
unlock blur

₹3 L/yr - ₹9.1 L/yr

arrow icon 83% more
Logo
unlock blur

₹4 L/yr - ₹9.3 L/yr

arrow icon 98% more
Logo
IQVIA Clinical Research Associate Salary

1 - 8 years exp. (69 salaries)

unlock blur

₹2.8 L/yr - ₹10.5 L/yr

arrow icon 78% more
Clinical Research Associate salary at Apollo Cancer Institute ranges between ₹2.9 Lakhs to ₹3.7 Lakhs per year for employees with less than 1 year of experience to 2 years. Salary estimates are based on 2 latest salaries received from various employees of Apollo Cancer Institute.

Similar Designation salaries in Apollo Cancer Institute

unlock blur
₹1.6 L/yr - ₹2.4 L/yr
unlock blur
₹1.9 L/yr - ₹2.5 L/yr
Pharmacist Salary
(AmbitionBox Estimate)
unlock blur
₹2.5 L/yr - ₹3.2 L/yr

Apollo Cancer Institute Clinical Research Associate Salary FAQs

What is the notice period for Clinical Research Associate at Apollo Cancer Institute?
According to AmbitionBox, 50% of the Apollo Cancer Institute Clinical Research Associates reported a notice period of 15 days or less, 50% reported a notice period of More than 3 months.This is based on 2 responses on AmbitionBox in last 2 years.

Tell us how to improve this page.

Apollo Cancer Institute Clinical Research Associate salary in India ranges between ₹2.9 Lakhs to ₹3.7 Lakhs. This is an estimate based on latest salaries received from employees of Apollo Cancer Institute.